Abstract: An alkali-cleavable heterobifunctional cross-linking analytical reagent is provided in the form of a compound having the structure ##STR1## in which R.sub.1 and R.sub.2 is each an alkylene group having from 2 to 4 carbon atoms.
Abstract: A 1-substituted-3-permissibly-substituted-6 (or 7)-oxodecahydroquinoline is converted to the corresponding 7 (or 6)-formyl derivative. The 6-oxo-7-formyl compound, upon treatment with hydrazine, is cyclized to a tautomeric mixture of 5-substituted-7-permissibly-substituted-4,4a,5,6,7,8,8a,9-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines.
Abstract: The new compound N-(dichlorofluoromethylthio)-3,4-dimethylmaleimide can be prepared by reacting 3,4-dimethylmaleimide with dichlorofluoromethanesulphenyl chloride in the presence of an acid-binding agent. N-(dichlorofluoromethylthio)-3,4-dimethylmaleimide is an active compound in microbicidal agents.
Type:
Grant
Filed:
April 9, 1985
Date of Patent:
February 24, 1987
Assignee:
Bayer Aktiengesellschaft
Inventors:
Engelbert Kuhle, Wilfried Paulus, Hermann Genth
Abstract: A novel compound useful in detecting leukocytes, esterase and protease in a test sample. The compound has the structure ##STR1## in which: A is an acid residue, R is lower alkyl, aryl, carboxyl, carboxyl ester, amido or cyano, R* is H or lower alkyl, and X is O, S, or NR', in which R' is H, lower alkyl or aryl.
Type:
Grant
Filed:
April 6, 1984
Date of Patent:
February 24, 1987
Assignee:
Miles Laboratories, Inc.
Inventors:
Paul F. Corey, Frederick E. Ward, Kin F. Yip, Meitak T. Yip
Abstract: Production of N-arylhalopyrrolidones by intramolecular cyclization of an .alpha.-halogen-N-2-alkenylamide is conducted in the presence of a copper-containing catalyst and a primary or secondary aliphatic amine.
Type:
Grant
Filed:
February 25, 1985
Date of Patent:
February 24, 1987
Assignee:
Stauffer Chemical Company
Inventors:
Michael D. Broadhurst, Richard D. Gless, Jr.
Abstract: 5-Amino-3-oxo-4-(substituted-phenyl)-4-pyrroline and derivatives thereof. The compounds generally exhibit both pre-emergence and post-emergence phytotoxicity and are useful as herbicides and also plant growth regulating agents at low dosages.
Abstract: A process for the extraction of aromatic (e.g., phenyl-containing) amino acids from an aqueous phase (solution) containing them, comprising combining the aqueous phase with a tenside of the formulaR--U--SO.sub.3 XwhereinR is alkyl or cycloalkyl each of 4-18 carbon atoms; or phenyl or naphthyl, each optionally substituted by alkyl groups, and having up to 18 carbon atoms total.U is a carbon-to-sulfur bond or an oxygen atom, andX is an alkali metal ion;acidifying the aqueous phase to a pH value of 2.0-2.5; andextracting the aqueous phase with an alcohol, a ketone, or a carboxylic acid alkyl ester, each containing 4-6 carbon atoms.
Type:
Grant
Filed:
January 11, 1985
Date of Patent:
February 17, 1987
Assignee:
Schering Aktiengesellschaft
Inventors:
Alfred Weber, Detlef Wilke, Johannes Kurzidim, Mario Kennecke
Abstract: A new process for the preparation of 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinones from anthranilic acid derivatives is described herein. Additional reactants used in the process are 4-aminotetrazole and a trialkoxymethane or the reaction can be carried out using the imidic ester obtained from these two compounds.
Abstract: Imidazopyrimidinones and other diazaheterocyclopyrimidinones having an additional fused imidazole or triazole ring have utility as bronchodilators, mediator release inhibitors, phosphodiesterase inhibitors, and peripheral vasodilators. They are orally active and useful in the prophylaxis and treatment of asthma. A preferred compound is 4-[(4-chlorophenyl)methyl]-6,7-dihydro-3H-imidazo[1,2-a]-purin-9(4H)-one.
Abstract: There are disclosed compounds of the formula ##STR1## wherein Z is CR or N, when n=1; or Z is O, S, or NR, when n=0; n is 0 or 1; p is 1-10; R.sup.1 is hydrogen, loweralkyl, loweralkoxy or halo; R.sup.2 is hydrogen, loweralkyl, loweralkoxy or halo; or R.sup.1 and R.sup.2 taken together form a benzene ring; and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstructive airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like.
Type:
Grant
Filed:
May 21, 1985
Date of Patent:
February 10, 1987
Assignee:
American Home Products Corporation
Inventors:
Anthony F. Kreft, III, Thomas W. Pattison, John H. Musser
Abstract: The present invention relates to a method for the recrystallization of the high explosives HMX and RDX. According to the invention, the explosive is dissolved in a low molecular weight, liquid (at room temperature) lactone, after which the degree of saturation of the solution obtained, is changed by either lowering the temperature or by diluting with water.This method produces, depending on the crystallization method chosen, .beta.-HMX crystals or RDX crystals of either 50-1500 .mu.m or 5-50 .mu.m median particle diameter respectively.
Type:
Grant
Filed:
March 26, 1985
Date of Patent:
January 20, 1987
Assignee:
Aktiebolaget Bofors
Inventors:
Leif Svensson, Jan-Olof Nyqvist, Lars Westling
Abstract: New process for preparing olefinic lactams by decomposing the corresponding N,N-dimethyl-N-oxides in a suitable solvent in the presence of a base at a temperature of at least 100.degree. C.
Abstract: A process for preparing compounds (1) ##STR1## where Y is NR.sup.1 R.sup.2 or OR, R.sup.1 and R.sup.2 are hydrogen or C.sub.1-3 alkyl, and R is C.sub.1-3 alkyl, which comprises protecting the hydroxy group of a compound (2) ##STR2## cyclising the product under basic conditions and removing the protecting group.
Abstract: A process for preparing 1-alkyl-6-oxodecahydroquinolines in 5 steps--a quaternization, hydrogenation, two organometallic reductions and hydrolysis of the thus formed enol ether--from 6-alkyloxyquinoline and intermediates useful therein.
Abstract: Oxindole compounds of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.1', R.sup.2', R.sup.3', R.sup.4, R.sup.5 and R.sup.6 have the meanings given, and physiologically acceptable salts thereof, for the treatment of epilepsy and their use for the preparation of a medicament for the treatment of epilepsy are described.
Abstract: Novel peptide B-52653 having the formula: ##STR1## which is produced by cultivating a microorganism belonging to the genus Streptomyces and being capable of producing B-52653 in a culture medium, whereby B-52653 is elaborated and accumulated in the cultured broth and is recovered.B-52653 is useful as a germicide or disinfectant, and a possibility of the present substance as an antifibrotic agent is suggested.
Abstract: There is provided a novel process for the preparation of carboxylic acids from alkyl groups under basic conditions utilizing oxides of copper, cobalt and silver.
Abstract: A method for the production of maleimides, which comprises subjecting maleinamic acids to ring-closure imidation in an organic solvent capable of forming an azeotrope with water in the presence of an acid catalyst at a temperature in the range of 120.degree. to 250.degree. C. while removing the formed water in the form of an azeotrope with said organic solvent and thereafter purifying the produced maleimides.
Abstract: A process for the protection of cultivated plants against harmful effects of aggressive agricultural chemicals by the use of compounds of the formula I ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 independently of one another are each hydrogen, halogen, C.sub.1 -C.sub.3 -alkyl, C.sub.1 -C.sub.3 -alkoxy, nitro or cyano,R.sub.4, R.sub.5 and R.sub.6 independently of one another are each hydrogen, halogen or C.sub.1 -C.sub.3 -alkyl,A is any one of the groups --CH.sub.2 --, --CH.sub.2 --CH.sub.2 -- or --CH(CH.sub.3)--, andZ is cyano, or amidoxime which can be acylated on the oxygen atom,including acid addition salts and metal complexes thereof.
Abstract: Herein is disclosed bicyclic-substituted aminoethanol derivatives, therapeutically acceptable acid addition salts thereof, processes for their preparation, methods of using the derivatives and pharmaceutical compositions. The derivatives are useful for treating hypertension in a mammal.
Type:
Grant
Filed:
May 23, 1985
Date of Patent:
November 11, 1986
Assignee:
American Home Products Corporation
Inventors:
Andre A. Asselin, Danilo A. Crosilla, Leslie G. Humber